scholarly journals TCT-481 Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Left Main Coronary Disease with Reduced Left Ventricular Ejection Fraction

2015 ◽  
Vol 66 (15) ◽  
pp. B196-B197 ◽  
Author(s):  
Hee-Soon Park ◽  
Jae-Hyung Roh ◽  
Pil Hyung Lee ◽  
Mineok Chang ◽  
Sung-Han Yoon ◽  
...  
Keyword(s):  
Percutaneous Coronary Intervention ◽  
Coronary Artery ◽  
Artery Bypass ◽  
Coronary Intervention ◽  
Left Ventricular ◽  
Left Ventricular Ejection ◽  
Bypass Grafting ◽  
Left Main ◽  
Ventricular Ejection Fraction ◽  
Percutaneous Coronary

Percutaneous coronary intervention for unprotected and protected left main stem disease

2010 ◽  
pp. 313-332
Author(s):  
Christine Hughes ◽  
Bruno Farah ◽  
Jean Fajadet
Keyword(s):  
Percutaneous Coronary Intervention ◽  
Coronary Artery ◽  
Left Main Coronary Artery ◽  
Artery Bypass ◽  
Coronary Bypass ◽  
Coronary Intervention ◽  
Bypass Grafting ◽  
Left Main ◽  
Coronary Bypass Grafting ◽  
Percutaneous Coronary

Significant unprotected left main coronary artery (ULMCA) disease occurs in 5–7% of patients undergoing coronary angiography (and patients with ULMCA disease treated medically have a 3-year mortality rate of 50%. Several studies have shown a significant benefit following treatment of left main (LM) stenosis with coronary bypass grafting compared with medical treatment. Until recently coronary bypass grafting has been the gold standard therapy for LM disease. However, advances in percutaneous intervention techniques and stent technology have allowed re-evaluation of the role of percutaneous coronary intervention (PCI) for LM disease. Recent studies have focused on the safety and efficacy of stenting the left main coronary artery (LMCA) to determine if it does provide a true alternative to coronary artery bypass grafting (CABG). So should we stent the LM?

Sign in / Sign up

Export Citation Format

Share Document